SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 196 filers reported holding SAGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $643,000 | -5.7% | 8,908 | +83.2% | 0.02% | -8.7% |
| Q3 2019 | $682,000 | -24.6% | 4,863 | -1.6% | 0.02% | -23.3% |
| Q2 2019 | $905,000 | -74.0% | 4,941 | -77.4% | 0.03% | -73.2% |
| Q1 2019 | $3,479,000 | +69.0% | 21,875 | +1.8% | 0.11% | +55.6% |
| Q4 2018 | $2,059,000 | -56.4% | 21,491 | -35.7% | 0.07% | -48.2% |
| Q3 2018 | $4,724,000 | +21.0% | 33,442 | +34.1% | 0.14% | +19.8% |
| Q2 2018 | $3,904,000 | -14.8% | 24,938 | -12.3% | 0.12% | -26.1% |
| Q1 2018 | $4,580,000 | -3.5% | 28,433 | -1.3% | 0.16% | -2.5% |
| Q4 2017 | $4,744,000 | +246.8% | 28,803 | +31.1% | 0.16% | +242.6% |
| Q3 2017 | $1,368,000 | -58.6% | 21,964 | -47.0% | 0.05% | -62.1% |
| Q2 2017 | $3,301,000 | +72.8% | 41,446 | +54.2% | 0.12% | +77.1% |
| Q1 2017 | $1,910,000 | -38.8% | 26,871 | -56.1% | 0.07% | -34.6% |
| Q4 2016 | $3,122,000 | – | 61,142 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |